KEGG   DRUG: Inbakicept
Entry
D11747                      Drug                                   
Name
Inbakicept (USAN/INN)
Formula
C2980H4624N800O894S28
Exact mass
66817.3138
Mol weight
66859.30
Sequence
ITCPPPMSVE HADIWVKSYS LYSRERYICN SGFKRKAGTS SLTECVLNKA TNVAHWTTPS
LKCIREPKSC DKTHTCPPCP APELLGGPSV FLFPPKPKDT LMISRTPEVT CVVVDVSHED
PEVKFNWYVD GVEVHNAKTK PREEQYNSTY RVVSVLTVLH QDWLNGKEYK CKVSNKALPA
PIEKTISKAK GQPREPQVYT LPPSRDELTK NQVSLTCLVK GFYPSDIAVE WESNGQPENN
YKTTPPVLDS DGSFFLYSKL TVDKSRWQQG NVFSCSVMHE ALHNHYTQKS LSLSPGK
(Disulfide bridge: 3-45, 29-63, 76-76', 79-79', 111-171, 217-275, 3'-45', 29'-63', 111'-171', 217'-275')
  Type
Peptide
Class
Antineoplastic
 DG02938  Immune checkpoint inhibitor
Remark
Product (mixture): D12888<US>
Efficacy
Antineoplastic
Target
PDL1 (CD274) [HSA:29126] [KO:K06745]
IL15RA (CD215) [HSA:3601] [KO:K05074]
  Pathway
hsa04060  Cytokine-cytokine receptor interaction
hsa04514  Cell adhesion molecule (CAM) interaction
hsa04630  JAK-STAT signaling pathway
hsa05200  Pathways in cancer
Brite
Drug groups [BR:br08330]
 Antineoplastic
  DG02938  Immune checkpoint inhibitor
   D11747  Inbakicept
Target-based classification of drugs [BR:br08310]
 Signaling molecules and receptors
  Cytokine receptors
   Interleukin receptors
    IL15RA (CD215)
     D11747  Inbakicept (USAN/INN)
 Cell surface molecules and ligands
  Other cell surface molecules
   Immune checkpoints
    PDL1 (CD274)
     D11747  Inbakicept (USAN/INN)
Other DBs
CAS: 2135939-52-3
PubChem: 405226613
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system